Fierce Pharma May 20, 2024
Nick Paul Taylor

A survey has shown the demographics most likely to be distrustful of the FDA. The results suggest the agency needs to win the trust of conservative women in rural communities who are in poor health or dissatisfied with their healthcare.

Earlier studies showed a sizable slice of the public is skeptical of the FDA, with one survey finding 23% of respondents either didn’t trust the agency very much or had zero faith in the organization. But, while the studies showed trust in the FDA is at a low ebb, there remained gaps in understanding of exactly who is skeptical of the agency and why.

A team at Brigham and Women’s Hospital tried to fill those gaps by surveying 2,021...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider, Survey / Study, Trends
Related Articles:
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article